---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-221224"
form_type: "8-K"
ticker: "AGIO"
cik: "0001439222"
company_name: "AGIOS PHARMACEUTICALS, INC."
filed_at: "2022-08-15T23:59:59+00:00"
generated_at: "2026-06-23T23:47:21.114822+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Agios Pharmaceuticals elects Rahul Ballal and Cynthia Smith as new directors

## Summary
- Board elected Rahul Ballal, Ph.D. and Cynthia Smith as Class I directors on Aug 11, 2022, effective immediately.
- Each new director receives annual cash compensation of $50,000 and initial equity grants: 37,947 options at $25.99 and 6,906 RSUs.
- Options vest 25% on first anniversary, remainder over 36 months; RSUs vest 1/3 annually over three years.
- Both directors entered standard indemnification agreements with the Company.

## SEC filing metadata
- accession: 0001193125-22-221224
- form_type: 8-K
- ticker: AGIO
- cik: 0001439222
- company_name: AGIOS PHARMACEUTICALS, INC.
- filed_at: 2022-08-15T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1439222/000119312522221224/0001193125-22-221224-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1439222/000119312522221224/d339643d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-221224
- JSON: https://secwatch.observer/filing/0001193125-22-221224.json
- Plain text: https://secwatch.observer/filing/0001193125-22-221224.txt

## Key facts
- Executive change
  Cynthia Smith was elected as director at AGIOS PHARMACEUTICALS, INC..
  - Action: elected
  - Role: director
  source text: On August 11, 2022, the Board of Directors (the “Board”) of Agios Pharmaceuticals, Inc. (the “Company”), upon the recommendation of the Board’s Nominating and Corporate Governance Committee (the “Corporate Governance Committee”), elected Rahul Ballal, Ph.D. and Cynthia Smith as directors.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1439222/000119312522221224/0001193125-22-221224-index.htm
- Executive change
  Rahul Ballal was elected as director at AGIOS PHARMACEUTICALS, INC..
  - Action: elected
  - Role: director
  source text: On August 11, 2022, the Board of Directors (the “Board”) of Agios Pharmaceuticals, Inc. (the “Company”), upon the recommendation of the Board’s Nominating and Corporate Governance Committee (the “Corporate Governance Committee”), elected Rahul Ballal, Ph.D. and Cynthia Smith as directors.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1439222/000119312522221224/0001193125-22-221224-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.